Biopharma SCMInnovate 2018

2018년 11월 1-2일 • 싱가포르, One Farrer Hotel & Spa

개요

세계의 생물의약품 물류 관련 지출은 수요 확대에 따라 계속 상승하고 있으며, 2021년에는 콜드체인과 기타 물류에서의 지출 총액이 931억 달러에 달할 전망입니다. 이 중 아시아태평양의 콜드체인 물류 시장 규모는 2019년에 12억 달러를 넘어서며 세계 시장에서 최대 점유율을 차지할 것으로 예상됩니다. 또한 기술의 진보에 수반하여 공급망 변혁에 대한 기세도 커지고 있으며, 시장의 성장과 기술 혁신이라는 2가지 요인의 조합으로 거대한 비지니스 기회가 생성됩니다. 공급망 관리(SCM) 분야의 기술 혁신은 제약 업계 공급망의 시급한 우려 및 문제에 대한 대응이라는 점에서 중요한 의미를 가지고 있습니다.

Biopharma SCMInnovate에서는 아시아를 비롯한 세계 각 지역 제약회사의 실무에 준거한 사례 연구가 소개되며, 공급망과 제품수명주기에 영향을 미치고 있는 다양한 요인에 대해 논의합니다. 이 이벤트의 목적은 물류/공급망 부문 책임자, 구매 담당자, 조달 책임자, 프로젝트 플래너, 물류 솔루션 프로바이더의 임원 등이 한자리에 모여 제약 업계의 베스트 프랙티스에 대해 의견을 교환하는 장소를 제공하는 것입니다.

컨퍼런스 하이라이트:

  • 운송 제품의 이력추적, 가시성, 보안을 확보하기 위한 방안 파악
  • 아시아 지역의 사례 연구 및 제약회사로부터 실용적인 정보 획득
  • 디지털화의 다양한 요소를 공급망 관리에 통합하는 방법 파악
  • 사업을 발전시키기 위한 새로운 비지니스 모델에 대해 파악
  • 강화된 제3자 물류(3PL)용 보관 공정과 전략의 최적화에 대해 파악
  • 신뢰성 높은 재고 관리 전략과 수요 예측에 대해 파악
  • 공급망 관리에 관한 판례법 사례와 시나리오에 관한 강연 청취
  • 공급망의 변혁을 추진하고 수익성을 높이는 방법 파악
  • 공급망을 보호하기 위한 기술 및 위조 방지 대책의 도입 방법 파악
  • 조달에 관한 현명한 판단과 공급업체 리스크의 효과적인 관리를 실현하기 위한 정보 획득
  • 콜드체인의 특정 요구를 충족시키는 최적의 패키지에 대해 파악
  • 데이터 로깅과 분석 기술의 진보에 관한 최신 정보 획득
  • 온도 관리를 실현하고 온도 일탈(temperature excursions)을 최소한으로 억제하는 방법 파악
  • 제품수명주기 및 이해관계자와의 관계의 관리에 대해 파악

동시 개최 이벤트

4th Annual Bioprocess and Technology 2018 >>
Biotech Investment Summit >>

아젠다

8:50 am

Chairperson's Opening Remarks

BIOPHARMA DEVELOPMENT AND PRODUCTION 2018 OPENING PLENARY SESSIONS

9:00 am

  • Designing, devising and implementing innovative R&D strategies with a focus on value-creation
  • Building and managing cost-effective and functional organizations and operations
  • Establishing key collaborations with government, academia and biotech to expand drug access

9:30 am

  • AI applications in biopharma market value chain - R&D, clinical trials, business process management and supply chain
  • Using AI tools in pharma - How Asia is progressing?

10:00 am

  • Analyzing latest biopharma trends and current unmet needs
  • Biopharma business models to capture market value
  • Lowering the cost-of-goods through cost-effective biomanufacturing strategies
  • Effectively forecasting market demand and managing drug supply to patients
  • Integrating entire biopharma value-chain for better speed to market

10:40 am

Morning Break and Networking. End of opening plenary and Biopharma SCM Innovate Conference Commences

RETHINKING BIOPHARMA SCM

11:20 am

Chairman's Opening Remarks

Yoram Eshel, Former Senior Director, Global Transportation and Logistics, Teva

11:30 am

  • Where is Pharma Supply Chain disruption coming from?
  • What are the effects of evolution in communication and traceability?
  • How is Amazon affecting the pharma supply chain?
  • What changes must supply chain professionals expect in the next 2-3 years?
  • Discover new business models to drive your team forward

12:00 pm

  • Examining our role in today's connected healthcare
  • How can supply chain transformation improve bottom-line?
  • AI in supply chain, how are pharma companies looking into AI solutions?
  • Cell and gene therapy personalised supply chain
  • What will be the direction of cold-chain and non-cold-chain logistics?
  • Dealing with different go-to-market models in different SEA countries
  • Ensuring sustainability and social responsibility

1:00 pm

Networking Lunch

2:00 pm

  • Aligning with Third Party Logistics providers and technology
  • How to effectively manage cold-chain and logistics - are IoT and Data Analytics the answers?
  • Mitigate risk by knowing what to look for in a partner
  • Framework for efficient collaboration

2:30 pm

ADVANCED THERAPEUTICS AND LARGE MOLECULE SCM

3:00 pm

  • Market size and demand
  • Supply chain requirement differences for monoclonal antibody and autologous cell therapy
  • Technical requirements and supply chain considerations for personalised cell and gene

3:30 pm

Afternoon Networking & Refreshment Break

4:00 pm

  • Risk assessment of your supply chain
  • Maintaining the integrity of the product in a temperature sensitive products
  • Security of the supply chain for controlled substances

4:30 pm

  • A look at the challenge of bioprocess and importance of COGs
  • Improving processing time with new protocol of cell seed preparation for large scale manufacture
  • Reduced costs from CQA analytical comparison between the alternative methods

5:00 pm

  • What leadership traits are essential for a high-performance supply chain?
  • Utilizing partners to optimize the supply chain
  • Need for Systems: how to efficiently manage large orders from distributors

5:30 pm

End of Conference Day One. Followed by Networking Cocktail

8:50 am

Chairman's Opening Remarks

INNOVATION IN SCM

9:40 am

  • What makes Asia's pharma supply chain unique?
  • Pharma Cold chain FTL/FCL opportunities
  • Challenges and successes: Cross dock hub transporting by ocean to the rest of the region

10:10 am

  • Challenges and complexity in clinical trials
  • Mitigating risks
  • Solutions and opportunities

10:40 am

Morning Networking & Refreshment Break

11:10 am

  • How manufacturers looking towards manufacturing for patients?
  • Smart devices for better supply planning
  • Addressing cold chain and personalized medication
  • Balancing cost and affordability to patients by reducing the costs of SCM

11:40 am

Reducing Costs through Supply Chain Strategies

Jamaluddin Elis, Managing Director, Chulia Life Sciences

12:10 pm

  • How manufacturers looking towards manufacturing for patients?
  • Smart devices for better supply planning
  • Addressing on cold chain and personalized medication
  • Balancing cost and affordability to patients by reducing the costs of SCM

12:40 pm

Global and regional trends in Cold Chain Management

1:00 pm

Networking Lunch

2:00 pm

Pharma 4.0 and the future of Supply Chain

COMPLIANCE AND SECURITY

2:30 pm

  • Supporting management and audits with Standards
  • Value and applications of Compendia Standards along the Supply Chain
  • Compliant regulation to deal with impurities and packaging

3:00 pm

  • Integrating IOT Innovations into Supply Chain Management are aiding security
  • Latest technological advancements in data logging and analytics
  • Developments in Cyber security
  • Technologies and anti-counterfeiting measures to protect supply chains
  • CAPEX requirements

3:30 pm

Afternoon Networking & Refreshment Break

4:00 pm

  • Reviewing latest disruptions in the biopharma industry
  • Re-thinking manufacturing productivity and quality
  • Connecting human resources, data, machines and networks for better outcomes
  • Impacts of Industry 4.0 on drug financing and investment outlook
  • Data management, product traceability and supply chain security

5:00 pm

End of Conference

* 주최사의 사정에 의해 사전예고 없이 프로그램이 변경될 수 있습니다.

스폰서 모집

파트너십과 인지도 향상의 기회
이 이벤트에 스폰서로서 참가하면 생물의약품 공급망 시장을 선도하는 기업으로서의 지위를 확보하는 것이 가능하며, 브랜드 인지도를 높이고 마케팅 기회를 활용하기 위한 다양한 패키지도 마련되어 있습니다. 자세한 사항은 문의해주시기 바랍니다.

연사

Ming-Qiang Zhang

Vice-President, Research & Development, Amgen, China

Dr. Carl Firth

Founder and Chief Executive Officer, Aslan Pharmaceuticals Pte Ltd, Singapore

Piers Ingram

Chief Executive Officer, Hummingbird Bioscience, Singapore

Ryan Viegas

Head of Logistics - APAC, Teva

Jonathan Zhao

PhD, Co-founder and Chief Executive Officer, Hangzhou JUST Biotherapeutics, China

Yoram Eshel

Former Senior Director, Global Transportation and Logistics, Teva

Joshua Teck Choo

Supply Chain Director, Amgen

Ankur Khanna

Associate Director - Supply Chain Management, MSD

Ai-Leng Wong

Regional Supply Chain Manager, Astellas

Yogesh Lawania

General Manager Supply Chain, Biocon

Lily Lien

Project Director, TOT Biopharma

Roger Lee

Director, Singapore Institute of Materials Management (SIMM)

Ian Matthews

Asst Group CTO, NUHS

Donglian Liu

Vice President, TOT BIOPHARM

Leon Lam

Vice President and Head of Asia, Merit Medical

Serene Lee

CFO, Verita Healthcare

Anna Marie Alejandro

Regional Commercial Finance Manager, Menarini Asia Pacific

Vincent Wong

former Director Global Sourcing, Ab Sciex

Sachin Narkhede

Associate Director, PRA

Volker Cloos

Consultant Global Logistics Asia, Eli Lilly

Jamaluddin Elis

Managing Director, Chulia Life Sciences

Sherry Wang

Director, USP

Widyaretna Buenastuti

(former Legal Affairs Director, Pfizer) Founder & CEO, Prabu

Rajiv Aserkar

Head of Logistics and Supply Chain, S P Jain School of Global Management

Aloysius Cheang

Director, Cloud Security Alliance

CK Vishwakarma

Founder, IOTSG

Liang Tang

Vice President of Biologics Development and Manufacturing, WuXi Biologics, China

Joseph Albert

Chief Technical Officer - Engineering and Projects, AJ Pharma Holding, Malaysia

개최 기간 & 개최지

2018년 11월 1-2일

One Farrer Hotel & Spa
1 Farrer Park Station Road
Singapore 217562

Contact Person: Daniel Koh
DDI: (+65) 6705 7884
Fax: (+65) 6834 7892
Cell: (+65) 86870123
Email: danielkoh@onefarrer.com

파트너

Supporting Association
메일링 서비스
메일링 서비스